Evidence map›Paper›PMID 32046715›Full record

ArticleBMC complementary medicine and therapies2020

Effects of Qilin pills on spermatogenesis, reproductive hormones, oxidative stress, and the TSSK2 gene in a rat model of oligoasthenospermia.

Kaishu Zhang, Longlong Fu, Qi An, Weihong Hu, Jianxin Liu, Xiuming Tang, Yu Ding, Wenhong Lu, Xiaowei Liang, Xuejun Shang and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Endocrine Disrupting Agents: Toxicological Aspects on Male Reproduction.Reproductive sciences (Thousand Oaks, Calif.) · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Signatures of selection inEvolutionary applications · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Kaishu ZhangDepartment of Reproductive Medicine, the Affiliated Hospital of Qingdao University, Qingdao, 266000, China.
Longlong FuNational Health and Family Planning Key Laboratory of Male Reproductive Health, Department of Male Clinical Research, National Research Institute for Family Planning & WHO Collaborating Center for Research in Human Reproduction, Beijing, 100081, China.
Qi AnNational Health and Family Planning Key Laboratory of Male Reproductive Health, Department of Male Clinical Research, National Research Institute for Family Planning & WHO Collaborating Center for Research in Human Reproduction, Beijing, 100081, China.
Weihong HuDepartment of Reproductive Medicine, the Affiliated Hospital of Qingdao University, Qingdao, 266000, China.
Jianxin LiuDepartment of Reproductive Medicine, the Affiliated Hospital of Qingdao University, Qingdao, 266000, China.
Xiuming TangDepartment of Reproductive Medicine, the Affiliated Hospital of Qingdao University, Qingdao, 266000, China.
Yu DingDepartment of Reproductive Medicine, the Affiliated Hospital of Qingdao University, Qingdao, 266000, China.
Wenhong LuNational Health and Family Planning Key Laboratory of Male Reproductive Health, Department of Male Clinical Research, National Research Institute for Family Planning & WHO Collaborating Center for Research in Human Reproduction, Beijing, 100081, China.
Xiaowei LiangNational Health and Family Planning Key Laboratory of Male Reproductive Health, Department of Male Clinical Research, National Research Institute for Family Planning & WHO Collaborating Center for Research in Human Reproduction, Beijing, 100081, China.
Xuejun ShangDepartment of Andrology, Jinling Hospital Affiliated to Southern Medical University, Nanjing, 210002, China. shangxj98@sina.com.
Yiqun GuNational Health and Family Planning Key Laboratory of Male Reproductive Health, Department of Male Clinical Research, National Research Institute for Family Planning & WHO Collaborating Center for Research in Human Reproduction, Beijing, 100081, China. yqgu90@163.com.ORCID http://orcid.org/0000-0001-9848-811X
Qingdao University · CNNational Health and Family Planning Commission · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNSouthern Medical University · CN

Funding

Science and Technology Projects of National Research Institute for Family Planning, China 2017JY004
6 · The paper itself

Abstract

backgroundQilin pills (QLPs), a classic Traditional Chinese Medicine (TCM) formula for treating male infertility, effectively improve semen quality in clinical trials. This study was designed to evaluate the effects of QLPs on spermatogenesis, reproductive hormones, oxidative stress, and the testis-specific serinekinase-2 (TSSK2) gene in a rat model of oligoasthenospermia.

methodsForty adult male Sprague-Dawley (SD) rats were randomly divided into four groups. The rat model with oligoasthenospermia was generated by intragastric administration of tripterygium glycosides (TGs) once daily for 4 weeks. Then, two treatment groups were given different doses (1.62 g/kg and 3.24 g/kg) of QLPs once daily for 60 days. Sperm parameters, testicular histology and reproductive hormone measurements, oxidative stress tests, and TSSK2 expression tests were carried out.

resultsQLPs effectively improved semen parameters and testicular histology; restored the levels of FSH, LH, PRL, fT, and SHBG; reduced the levels of oxidative stress products (ROS and MDA); increased testicular SOD activity; and restored the expression of spermatogenesis-related gene TSSK2.

conclusionQLPs have a therapeutic effect on a rat model of oligoasthenospermia, and this effect is manifested as improvement of semen quality and testis histology, gonadal axis stability, decreased oxidative stress, and the regulation of testis-specific spermatogenesis-related gene TSSK2.

Indexed as

AnimalsChinaDisease Models, AnimalDrugs, Chinese HerbalGonadotropins, PituitaryHormonesMaleMedicine, Chinese TraditionalOligospermiaOxidative StressProlactinProtein Serine-Threonine KinasesRatsRats, Sprague-DawleySex Hormone-Binding GlobulinSpermatogenesisDrugs, Chinese HerbalGonadotropins, PituitaryHormonesProlactinProtein Serine-Threonine KinasesSex Hormone-Binding GlobulinTestosteroneTssk2 protein, mouseMale infertilityQilin pillsTraditional Chinese medicineTripterygium glycosidesTSSK2

Identifiers

PMID32046715
PMCPMC7076898
OpenAlexW3005764831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.